homocysteine has been researched along with gemcitabine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberola, V; Almenar, D; Artal, A; Barcelo, R; Bover, I; Camps, C; Cobo, M; de las Peñas, R; Diz, P; Garcia-Gomez, R; Gonzalez-Larria, JL; Insa, A; Isla, D; Massuti, B; Muñoz, MA; Rosell, R; Sanchez, JJ; Sanchez-Ronco, M; Sarries, C; Taron, M; Terrasa, J | 1 |
1 trial(s) available for homocysteine and gemcitabine
Article | Year |
---|---|
Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; DNA Methylation; Female; Gemcitabine; Genes, Tumor Suppressor; Genotype; Homocysteine; Humans; Lung Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome | 2004 |